Company Filing History:
4 out of 870 
4 out of 5,081 
2 out of 1,743 
Years Active: 2012-2019
Title: The Innovative Contributions of Farida Nato in Glycoconjugate Research
Introduction
Farida Nato, an accomplished inventor based in Antony, France, has made significant strides in the field of glycoconjugates, particularly in their potential applications as vaccines. With a total of six patents to her name, she has developed innovative compounds that help combat infections, paving the way for advancements in vaccine technology.
Latest Patents
One of her latest patents involves a conjugate that comprises an oligo- or polysaccharide selected from a specialized group designed to enhance vaccine efficacy against infections. Specifically, the invention details a conjugate formed from oligo- or polysaccharides, which are bound to a carrier to facilitate immune responses. Another patent focuses on compounds derived from sugars that replicate the epitopes of serotypes 3a and X, detailing the preparation of vaccine compositions. Her research delves into synthesizing novel glycoconjugated compounds and the methods for their application in diagnostics and vaccination.
Career Highlights
Farida Nato has a distinguished career that includes her contributions to prestigious institutions such as the Institut Pasteur and the Centre National de la Recherche Scientifique. Her involvement at these institutions has enriched her expertise and facilitated ground-breaking research in her areas of focus.
Collaborations
Throughout her career, Farida has collaborated with notable colleagues, including Armelle Phalipon and Laurence Mulard. These partnerships have played a crucial role in advancing her research initiatives and enhancing the impact of her inventions in the scientific community.
Conclusion
In summary, Farida Nato stands out as a pioneer in glycoconjugate research, with her innovative patents significantly contributing to the development of vaccines against infections. Her dedication and collaboration with esteemed colleagues underscore her commitment to advancing medical science and improving public health outcomes.